Leishmania (L.) infantum chagasi isolated from skin lesions of patients affected by non-ulcerated cutaneous leishmaniasis lead to visceral lesion in hamsters
Carregando...
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Autores
NUNES, Juliana B.
COLOMBO, Fabio A.
ZUNIGA, Concepcion
SILVEIRA, Fernando T.
Citação
PARASITOLOGY INTERNATIONAL, v.93, article ID 102723, 9p, 2023
Resumo
In Central America, Leishmania (L.) infantum chagasi infection causes visceral leishmaniasis (VL) and non -ulcerated cutaneous leishmaniasis (NUCL). The aim of the present study was to evaluate the course of an experimental infection in hamsters caused by L. (L.) infantum chagasi isolated from patients affected by NUCL compared with a strain isolated from a patient with VL. Stationary phase parasites in culture were inoculated through subcutaneous and intraperitoneal routes in hamsters. Following the post-infection times, a histopath-ological study, parasite load and cytokine determination in skin from the cutaneous inoculation site and viscera were performed. Animals subcutaneously infected with the different strains did not develop macroscopic lesions at the inoculation site, and the histopathological changes in the dermis were very slight. Regarding the histo-pathological study of the viscera, we observed the portal mononuclear inflammatory infiltrate, the presence of nodules in the hepatic parenchyma and the proliferation of macrophages in the spleen, which increased over the infection course. Overall, the parasite load in the liver and spleen and in the total IgG titres in the sera of infected hamster showed an increase with the time of infection, regardless of the route of inoculation. Regarding cellular immunity, we did not observe an increase or decrease in pro-and anti-inflammatory cytokines compared to the healthy control, except for IL-10, which was evident in the infected animals. The data showed that strains iso-lated from NUCL cause visceral lesions in the hamsters regardless of the route of inoculation, and they were similar to parasites isolated from VL humans.
Palavras-chave
Leishmania (L, ) infantum chagasi, Mesocricetus auratus, Experimental infection, Cytokines, Immunoglobulin
Referências
- Anam K, 1999, INFECT IMMUN, V67, P6663
- Andargie T.E., 2015, J CELL SCI R, V6, P1, DOI 10.4172/2157-7013.1000206
- ANDRADE ZILTON A., 1966, REV INST MED TROP SAO PAULO, V8, P259
- Antonelli LRV, 2004, CLIN EXP IMMUNOL, V136, P341, DOI 10.1111/j.1365-2249.2004.02426.x
- Flores GVA, 2020, PARASITE IMMUNOL, V42, DOI 10.1111/pim.12772
- Flores GVA, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/3487591
- Araujo-Santos T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04595-8
- Awasthi A, 2004, INDIAN J MED RES, V119, P238
- Bogdan C, 1998, INT J PARASITOL, V28, P121, DOI 10.1016/S0020-7519(97)00169-0
- Cardoso CA, 2020, MEM I OSWALDO CRUZ, V115, DOI 10.1590/0074-02760200140
- Carvalho LP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00301
- Cecilio P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00480
- Coelho-Finamore JM, 2011, INT J PARASITOL, V41, P333, DOI 10.1016/j.ijpara.2010.10.004
- CORBETT CEP, 1992, INT J EXP PATHOL, V73, P417
- Crescente JAB, 2009, T ROY SOC TROP MED H, V103, P1250, DOI 10.1016/j.trstmh.2009.06.010
- da Silva JC, 2020, ACTA TROP, V209, DOI 10.1016/j.actatropica.2020.105539
- Dea-Ayuela MA, 2007, VET RES COMMUN, V31, P703, DOI 10.1007/s11259-007-0040-5
- DUARTE MIS, 1987, REV INST MED TROP SP, V29, P131, DOI 10.1590/S0036-46651987000300003
- Engwerda CR, 2000, IMMUNOL TODAY, V21, P73, DOI 10.1016/S0167-5699(99)01549-2
- Engwerda CR, 2004, TRENDS PARASITOL, V20, P524, DOI 10.1016/j.pt.2004.08.009
- GALVAOCASTRO B, 1984, CLIN EXP IMMUNOL, V56, P58
- Garg R, 2006, INDIAN J MED RES, V123, P439
- Gautam S, 2011, J INFECT DIS, V204, P1134, DOI 10.1093/infdis/jir461
- Gupta G, 2013, ADV APPL MICROBIOL, V82, P155, DOI 10.1016/B978-0-12-407679-2.00005-3
- GUTIERREZ Y, 1984, AM J PATHOL, V114, P222
- Hermida MDR, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00394
- Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608
- Kaye PM, 2004, IMMUNOL REV, V201, P239, DOI 10.1111/j.0105-2896.2004.00188.x
- Kedzierski L, 2014, PARASITOLOGY, V141, P1544, DOI 10.1017/S003118201400095X
- Kumar R, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00251
- Laurenti MD, 2014, VET PARASITOL, V205, P444, DOI 10.1016/j.vetpar.2014.09.002
- Laurenti MD, 2022, PARASITE IMMUNOL, V44, DOI 10.1111/pim.12896
- LAURENTI MD, 1990, INT J EXP PATHOL, V71, P791
- Laurenti MD, 1996, INT J EXP PATHOL, V77, P15, DOI 10.1046/j.1365-2613.1996.958096.x
- Lima HC, 1997, PARASITOL TODAY, V13, P80, DOI 10.1016/S0169-4758(96)40010-2
- Mathias R, 2001, BRAZ J MED BIOL RES, V34, P539, DOI 10.1590/S0100-879X2001000400015
- McCall LI, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003053
- MCELRATH MJ, 1988, J EXP MED, V167, P1927, DOI 10.1084/jem.167.6.1927
- Mears ER, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003889
- Melby PC, 1998, INFECT IMMUN, V66, P18, DOI 10.1128/IAI.66.1.18-27.1998
- Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912
- Meleney HE, 1925, AM J PATHOL, V1, P147
- Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470
- Moreira ND, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1464-y
- Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741
- Murray HW, 2001, INT J EXP PATHOL, V82, P249, DOI 10.1046/j.1365-2613.2001.00199.x
- Mutiso Joshua Muli, 2013, Scientia Parasitologica, V14, P51
- Loria-Cervera EN, 2014, REV INST MED TROP SP, V56, P1, DOI 10.1590/S0036-46652014000100001
- Nieto A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-39
- Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004
- OPS, 2009, MAN MAN ENF PAR PRIO
- Peruhype-Magalhaes V, 2005, SCAND J IMMUNOL, V62, P487, DOI 10.1111/j.1365-3083.2005.01686.x
- PONCE C, 1991, LANCET, V337, P67, DOI 10.1016/0140-6736(91)90734-7
- Ramos PK, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6937980
- Requena JM, 2000, VET IMMUNOL IMMUNOP, V76, P269, DOI 10.1016/S0165-2427(00)00221-X
- Rica-Capela MJ, 2003, PARASITOL RES, V89, P163, DOI 10.1007/s00436-002-0738-9
- RIDLEY DS, 1983, J PATHOL, V141, P83, DOI 10.1002/path.1711410109
- RIDLEY MJ, 1986, BRIT J EXP PATHOL, V67, P209
- Saini S, 2020, PARASITE IMMUNOL, V42, DOI 10.1111/pim.12768
- Samant M, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.624009
- Sandoval C, 2021, J VENOM ANIM TOXINS, V27, DOI [10.1590/1678-9199-JVATITD-2020-0149, 10.1590/1678-9199-jvatitd-2020-0149]
- Pacheco CMS, 2021, J IMMUNOL RES, V2021, DOI 10.1155/2021/5596876
- Pacheco CMS, 2018, INT J EXP PATHOL, V99, P249, DOI 10.1111/iep.12295
- Santana CC, 2008, PARASITE IMMUNOL, V30, P515, DOI 10.1111/j.1365-3024.2008.01051.x
- SCHNUR L, 1973, EXP PARASITOL, V34, P432, DOI 10.1016/0014-4894(73)90103-3
- Silveira FT, 2009, PARASITE IMMUNOL, V31, P423, DOI 10.1111/j.1365-3024.2009.01116.x
- Silveira F.T., 2008, REV PARA MED, V22, P9
- Silveira F.T., 2021, RESOUR ANNOUNC, V10, P1, DOI [10.1128/MRA.00471-21, DOI 10.1128/MRA.00471-21]
- Silveira FT, 2010, T ROY SOC TROP MED H, V104, P529, DOI 10.1016/j.trstmh.2010.05.002
- Sosa-Ochoa W, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9070554
- Stanley AC, 2007, IMMUNOL CELL BIOL, V85, P138, DOI 10.1038/sj.icb7100011
- Tafuri Wagner Luiz, 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P81, DOI 10.1590/S0036-46651996000200001
- Tafuri WL, 2001, VET PARASITOL, V96, P203, DOI 10.1016/S0304-4017(00)00436-2
- TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x
- Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P229, DOI 10.1111/j.1574-695X.2007.00311.x
- WILSON ME, 1987, J PARASITOL, V73, P55, DOI 10.2307/3282344